News
Polpharma Biologics & Fresenius Kabi enter licensing agreement for proposed vedolizumab biosimilar, PB016: Amsterdam Wednesday, August 6, 2025, 11:00 Hrs [IST] Polpharma Biologics ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback